ClinicalTrials.gg
RecruitingNCT05415384Updated Nov 20, 2026

Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures

An interventional study of Cryoablation of Intercostal Nerves and Standard surgical treatment of patients with multiple rib fractures in Pain, Postoperative and Rib Fracture Multiple, sponsored by Wake Forest University Health Sciences. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2022; still recruiting 4 years 3 months later.
Updated Nov 20, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Pain, Postoperative by Wake Forest University Health Sciences — 2 open to participants now, 3 under way, 1 of them phase 3. Pain, Postoperative · Wake Forest University Health Sciences.

Planned enrollment
4th of 14
80 · median 63
Started
2022
with 2 others
No phase
4 of 15
1 open now
Registered
13th of 15
by date

Among the 15 studies in Pain, Postoperative by Wake Forest University Health Sciences, this one is the 4th largest by planned enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2022, is one of 4 with no phase, and was the 13th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

2 of the 15 studies in Pain, Postoperative by Wake Forest University Health Sciences are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Pain, Postoperative by Wake Forest University Health Sciences, or all of them as a file.
02

Study summary

To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation

Read the detailed description

Locoregional pain control with cryoneurolysis of intercostal nerves has been employed as an adjunct for longer term pain control. Initially introduced in thoracic surgery, intercostal nerve cryoablation has demonstrated adequate pain control and substantial decrease in opioid consumption and hospital length of stay.

03

Conditions studied

  • Pain, Postoperative
  • Rib Fracture Multiple

Browse trials for

Keywords

  • Locoregional pain
  • thoracotomy
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient is admitted to the trauma service.
  • The patient has multiple displaced rib fractures (≥2 ribs), offered fixation, and consents to SSRF
  • The patient is not being treated for chronic pain
  • The patient is >18 years of age.
  • Surgery anticipated \<120 hours from injury

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years or ≥ 80 years
  • Flail chest: either radiographic or clinical. Radiographic flail chest is defined on CT chest as ≥ 2 ribs each fractured in ≥ 2 places. Clinical flail is defined as visualization of a segment of chest wall with paradoxical motion on physical exam.
  • Moderate or severe traumatic brain injury (Intra-cranial hemorrhage visualized on CT head with GCS at the time of consideration for enrollment \< 12)
  • Prior or expected emergency exploratory laparotomy during this admission
  • Prior or expected emergency thoracotomy during this admission
  • Prior or expected emergency craniotomy during this admission
  • Spinal cord injury
  • Pelvic fracture that has required, or is expected to require, operative intervention during this admission
  • The patient was unable to accomplish activities of daily living independently prior to injury (e.g., dressing, bathing, preparing meals)
  • The patient is incarcerated
  • The patient is known to be pregnant
  • Unable to perform Video Assisted Thoracoscopy (VATS) at time of SSRF due to lung isolation or previous pathology
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Surgical Stabilization of Rib Fractures plus Multimodal Pain Therapy plus CRYOABLATION

    Adding Cryoablation of levels 3-8, in addition to patients that undergo SSRF for multiple rib fractures.

    Device: Cryoablation of Intercostal Nerves

  • Active comparator
    Surgical Stabilization of Rib Fractures plus Multimodal Pain Therapy

    Standard surgical treatment of patients with multiple rib fractures plus Multimodal Pain Therapy

    Procedure: Standard surgical treatment of patients with multiple rib fractures

Interventions

  • DeviceCryoablation of Intercostal Nerves

    Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.

  • ProcedureStandard surgical treatment of patients with multiple rib fractures

    Standard surgical treatment of patients with multiple rib fractures

06

What researchers measure

Primary outcomes

  1. Morphine Milligram Equivalents Use following Intervention

    To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.

    Time frame: Baseline

  2. Morphine Milligram Equivalents Use following Intervention

    To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.

    Time frame: Day 1

  3. Morphine Milligram Equivalents Use following Intervention

    To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.

    Time frame: Day 30

  4. Morphine Milligram Equivalents Use following Intervention

    To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.

    Time frame: Day 90

Secondary outcomes

  1. Number of days in Hospital Stay

    Hospital Length of Stay

    Time frame: Days during admission

  2. Number of days in ICU Stay

    ICU Length of Stay

    Time frame: Day 90

  3. Amount of Chest tube drainage

    Chest tube drainage

    Time frame: Day 90

  4. Quality of Life Scores

    Quality of Life questionnaire - Quality of life questionnaire consists of a set of survey questions that can be used to collect data related to an individual in particular and society in general on various parameters that determine their general quality of life

    Time frame: Month 1 and Month 3

  5. Number of Mortalities in hospital

    Mortality, in hospital

    Time frame: Day 90

  6. Number of Readmissions

    Readmission

    Time frame: 30 day readmission rate

  7. Number of Additional Thoracic Procedures

    Additional Thoracic Procedures

    Time frame: Day 7

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2022 (actual). Primary completion is estimated for May 2027, 57 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 57 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Nov 2026 → May 2027 and completion Nov 2026 → May 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2022
First posted
Jun 13, 2022
StartActual
Aug 1, 2022
Primary completionEst.
May 2027was Nov 2026
CompletionEst.
May 2027was Nov 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Nov 2026→May 2027
Nov 20, 2026
Study completion
Nov 2026→May 2027
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Primary completion Nov 2026→May 2027
    Study completion Nov 2026→May 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05415384
Responsible party
Sponsor
First posted
Jun 13, 2022
Start date
Aug 1, 2022
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Bradely W Thomas, MD
Contact
Bradley.Thomas@wfusm.edu
704-355-3176
Bradely W. Thomas, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion